Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
All content for IPWatchdog Unleashed is the property of Gene Quinn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
Patents vs. Trade Secrets: Do You Need a Patent, or is a Secret Good Enough?
IPWatchdog Unleashed
55 minutes
3 months ago
Patents vs. Trade Secrets: Do You Need a Patent, or is a Secret Good Enough?
This week on IPWatchdog Unleashed we explore the age-old question about whether it is best to keep an innovation as a trade secret or whether it makes sense to seek patent protection. And while this question is not one that is new, it is a question that has been getting more attention in recent years. And what I mean by that is this—it is hard not to notice that U.S. patents have been under siege for some time now. This has driven innovators into trade secret protection and away from patent p...
IPWatchdog Unleashed
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
